Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.

Drolet M, Laprise JF, Chamberland E, Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M.